Donal O'Connor
Director · Theravance Biopharma, Inc.
Individual
- 2026
- Sep 25, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Donal O'Connor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eli Samaha - $5.91M in TBPH purchases and sales in the last 12 months
- Eran Broshy - $1.66M in TBPH purchases and sales in the last 12 months
- Rhonda Farnum - $1.46M in TBPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Donal O'Connor?
Donal O'Connor is a corporate insider, tracked as Director of Theravance Biopharma, Inc. (TBPH). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donal O'Connor submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
